Biotest Pharmaceuticals has entered a 10-year deal to act as the exclusive global supplier to ADMA Biologics for respiratory syncytial virus immune globulin made from human plasma. As part of the agreement, ADMA secured the right to use Biotest's proprietary fractionation and purification technology for the production of intravenous immune globulin.
Biotest and ADMA Biologics agree to deal for immune globulin
SmartBrief Job Listings for Health Care
|Senior Director, Biostatistics||
|Associate - Food and Drug||
Keller and Heckman LLP
|Senior Paralegal - Research & Development, and Medical||